Mastering Tech Transfer to Quality Control Teams for Gene Therapy Potency Assays
Time: 8:30 am
day: Conference Day 2
Details:
This session offers a comprehensive deep dive into the critical process of tech transfer to Quality Control specifically for gene therapy potency assays. Attendees will explore the key steps involved in transferring assays from development to quality control, addressing common challenges, and discovering best practices to ensure a smooth transition.
The session will emphasize the importance of maintaining assay robustness and reproducibility, with techniques for validating assays during tech transfer and strategies to maintain performance and consistency. This interactive session provides a unique opportunity to gain practical insights and solutions that are not covered in the main conference sessions.
